Letters to the Editor

Curtis JC . The author responds [letter]. Can J Psychiatry 1998;43:853.

Merskey H . Regional pain is rarely hysterical. Arch Neurol 1988;45:915–8.

Merskey H . The manufacture of personalities. The production of multiple personality disorder. Br J Psychiatry 1992;160:327–40. Summarized in: Skeptical Inquirer 1992;17(Fall):86. Reprinted with correspondence in: Dissociative identity disorder. Cohen L Berzoff N Elin M , editors. Northvale (NJ): Jason Aronson Inc; 1995.

Merskey H . Ethical issues in the search for repressed memories. Am J Psychotherapy 1996;50:323–35.

Merskey H . The analysis of hysteria: Understanding conversion and dissociation. 2nd ed. London: Gaskell; 1995.

International classification of diseases and related health problems (ICD-10). 10th ed. Revised. Volume 1. Geneva: World Health Organization; 1992.

Piper A Jr . Hoax and reality: The bizarre world of multiple personality disorder. Northvale (NJ): Jason Aronson Inc; 1997.

Masand PS Tesar GE . Use of stimulants in the medically ill. Psychiatr Clin North Am 1996;19:515–47.

Bruera E Watanabe S . Psychostimulants as adjuvant analgesics. J Pain Symptom Manage 1994;9:412–5.

Sher L . The role of the immune system and infection in the effects of psychological factors on the cardiovascular system [letter]. Can J Psychiatry 1998;43:954–5.

Friedman EH . Left sided colon cancer [letter]. Gut 1994;35:286.

Friedman EH . Neurobiology of occupational differences in depression and global health [letter]. J Occup Environ Med 1998;40:839.

Lejeune F Millan MJ . Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)_A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and 15535. Synapse 1998;30:172–80.

Shively CA . Social subordination stress, behavior, and central monoaminergic function in female cynomologus monkeys. Biol Psychiatry 1998;44:882–91.

Sourer R Bremner JD Arrighi JA Cohen I Zaret BL Burg MM Goldman-Rate P . Cerebral cortical hyperactivation in response to stress in patients with coronary artery disease. Proc Natl Acad Sci U S A 1998;95:6454–9.

Repp BH . Variability of timing in expressive piano performance increases with interval duration. Psychonomic Bulletin and Review 1997;4:530–4.

Menon RS Luknowsky DC Gati JS . Mental chronometry using latency-resolved functional MRI. Proc Natl Acad Sci U S A 1998;95:10902–7.

Krimer LS Muly EC III Williams GV Goldman-Rakic PS . Dopaminergic regulation of cerebral cortical microcirculation. Nature Neuroscience 1998;11:286–9.

Iadecola C . Neurogenic control of cerebral microcirculation: Is dopamineing the store? Nature Neuroscience 1998;1:263–5.

Friedman EH . Re: Behavioural inhibition, attachment, and anxiety in children of mothers with anxiety disorders [letter]. Can J Psychiatry 1997;42:980.

Shima K Tanji J . Role for cingulate motor area cells in voluntary movement lection based on reward. Science 1998;282:1335–8.

Stanford L Santi A . The dopamine D2 agonist quinpirole disrupts attention temporal signals without selectively altering the speed of the internal clock. psychobiology 1998;26:258–66.

Friedman EH Cohen RA . Disruption of short-duration timing associated with damage to the suprachiasmatic region of the hypothalamus [letter and reply]. Neurology 1998;51:919–20.

Amrein R Hetzel W Stabi M Schmid-Burgk W . RIMA—a new concept in the treatment of depression with moclobemide. Int Clin Psychopharmacol 1993;7(3–4):123–32.

Al Jeshi A Jeffries JJ Kennedy S . Overview of new antidepressants. Saudi Medical Journal 1996;17:559–69.

Youdim MB . The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction [review]. Acta Psychiatr Scand Suppl 1995;386:5–7.

Nair NP Ahmed SK Kin NM West TE . Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients [review]. Acta Psychiatr Scand Suppl 1995;386:28–35.

Bezchlibnyk-Butler KZ Jeffries JJ , editors. Clinical handbook of psychotropic drugs. 6th ed. Seattle: Hogrefe and Huber; 1996.

Rosenbaum JF Fava M Hoog SL Ascroft RC , and Krebs WB . Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial. Biol Psychiatry 1998;44:77–87.

Taylor DP Carter RB Eison AS Mullins UL Smith HL , Torrente JR, and others. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995;56 Suppl 6: 3–11.

Benazzi F . Nefazodone withdrawal symptoms [letter]. Can J Psychiatry 1998;43: 194–5.

Schatzberg AF Haddad P Kaplan EM Lejoyeux M Rosenbaum JF , Young AH, and others. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition. J Clin Psychiatry 1997;58 Suppl 7: 5–10.

Schatzberg AF Haddad P Kaplan EM Lejoyeux M Rosenbaum JF , Young AH, and others. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. J Clin Psychiatry 1997;58 Suppl 7: 23–7.

Thierren F Markowitz JS . Selective serotonin reuptake inhibitors and withdra symptoms: A review of the literature. Human Psychopharmacology 1997;12:309–23.

Price JS Waller PC Wood SM Mackay AVP . A comparison of the postmarketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996;42:757–63.

Dallai A Chouinard G . Withdrawal and rebound symptoms associated with abrupt discontinuation with venlafaxine. J Clin Psychopharmacol 1998;18:343–4.

Benazzi F . Nefazodone withdrawal symptoms [letter]. Can J Psychiatry 1998;43:194–5.

Greene DS Salazar DE Dockens RC Kroboth P Barbhaiya RH . Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction with alprazolam. J Clin Psychopharmacol 1995;15:399–408.

Nielsen KK Flinois JP Beaune P Brosen K . The biotransformation of clomipramine in vitro, identification of the cytochrome P450s for the separate metabolic pathways. J Pharmacol Exp Ther 1996;277:1659–64.

Benazzi F . Nefazodone withdrawal symptoms [letter]. Can J Psychiatry 1998;43:194–5.

Coupland NJ Bell CJ Potokar JP . Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356–62.

Benazzi F . Venlafaxine withdrawal symptoms [letter]. Can J Psychiatry 1996;41:487.

Greene DS Salazar DE Dockens RC Kroboth P Barbhaiya RH . Coadministration of nefazodone and benzodiazepine: III. A pharmacokinetic interaction study with alprazolam. J Clin Psychopharmacol 1995; 15:399–408.

DeVane CL . Principles of pharmacokinetics and pharmacodynamics. In: Schatzberg AF Nemeroff CB . Textbook of psychopharmacology. 2nd ed. Washington (DC): American Psychiatric Press; 1998. p 155–69.

Schatzberg AF Haddad P Kaplan EM Lejoyeu M Rosenbaum JF , Young AH, and others. Serotonin reuptake discontinuation syndrome: A hypothetical definition. J Clin Psychiatry 1997;58 Suppl 7: 5–10.

Nemeroff CB DeVane CL Pollock BG . Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311–20.